deafness | GenomeWeb

deafness

BEIJING — Like many microarray vendors, CapitalBio sees future growth opportunities in molecular diagnostics.

By Molika Ashford
In the hunt for the genetic causes of hearing loss in local populations, researchers at Tel Aviv University have taken up targeted genomic capture and deep sequencing to root out causative mutations.

At an FDA workshop last month, Lynn Bry spoke in a panel session about the need for a clinically annotated database of variants, detailing how Partners HealthCare Center for Personalized Medicine had developed such a database that is using for its sequencing-based diagnostic tests.

"Next-gen sequencing is going to turn diagnostics completely upside down and on its head," Richard Resnick, CEO of GenomeQuest, said at a recent panel discussion on next-gen sequencing-based diagnostics.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.